NAPG Antibody (Center) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q99747 |
---|---|
Clone Names | 100528105 |
Gene ID | 8774 |
---|---|
Other Names | Gamma-soluble NSF attachment protein, SNAP-gamma, N-ethylmaleimide-sensitive factor attachment protein gamma, NAPG, SNAPG |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | NAPG (HGNC:7642) |
---|---|
Function | Required for vesicular transport between the endoplasmic reticulum and the Golgi apparatus. |
Cellular Location | Membrane {ECO:0000250|UniProtKB:P81127}; Peripheral membrane protein {ECO:0000250|UniProtKB:P81127}. Golgi apparatus {ECO:0000250|UniProtKB:Q9CWZ7} |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
This gene encodes soluble NSF attachment protein gamma.The soluble NSF attachment proteins (SNAPs) enableN-ethyl-maleimide-sensitive fusion protein (NSF) to bind to targetmembranes. NSF and SNAPs appear to be general components of theintracellular membrane fusion apparatus, and their action atspecific sites of fusion must be controlled by SNAP receptorsparticular to the membranes being fused. The product of this genemediates platelet exocytosis and controls the membrane fusionevents of this process.
References
Yosifova, A., et al. J Affect Disord 117 (1-2), 87-97 (2009) :Li, X., et al. Neurosci. Lett. 457(3):159-162(2009)Lamesch, P., et al. Genomics 89(3):307-315(2007)Weller, A.E., et al. Psychiatr. Genet. 16(1):3-8(2006)Rush, J., et al. Nat. Biotechnol. 23(1):94-101(2005)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.